Sammy J. Farah - Jul 20, 2023 Form 3 Insider Report for Turnstone Biologics Corp. (TSBX)

Role
President & CEO, Director
Signature
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
Stock symbol
TSBX
Transactions as of
Jul 20, 2023
Transactions value $
$0
Form type
3
Date filed
7/20/2023, 09:50 PM
Next filing
Oct 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TSBX Employee Stock Option (Right to Buy) Jul 20, 2023 Common Stock 115K $1.51 Direct F1
holding TSBX Employee Stock Option (Right to Buy) Jul 20, 2023 Common Stock 25.3K $1.59 Direct F1
holding TSBX Employee Stock Option (Right to Buy) Jul 20, 2023 Common Stock 92.7K $1.59 Direct F1
holding TSBX Employee Stock Option (Right to Buy) Jul 20, 2023 Common Stock 305K $9.34 Direct F1
holding TSBX Employee Stock Option (Right to Buy) Jul 20, 2023 Common Stock 238K $10.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.
F2 One fourth (1/4th) of the shares subject to the option award vested on January 20, 2023, and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney